JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marelli, D.
Right arrow Articles by Chiu, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marelli, D.
Right arrow Articles by Chiu, R. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 751-756, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? A prospective randomized study

D Marelli, A Paul, R Samson, D Edgell, P Angood and RC Chiu
Department of Surgery, Montreal General Hospital/McGill University, Quebec Canada.

Colloid solution is commonly used to increase the oncotic pressures of priming solutions used in the cardiopulmonary bypass circuit. To study the effectiveness of this practice, we prospectively randomized 100 adult patients undergoing cardiac operations to receive Ringer's lactate solution plus 50 gm of albumin (group A) or Ringer's lactate solution alone (group B) as the prime solution for the bypass circuit. Personnel involved in the management of these patients were blinded concerning the group to which the patients had been randomized. Forty clinical parameters related to perioperative fluid balance, cardiopulmonary function, and renal function were studied. Although group B received a larger volume of crystalloid solution intraoperatively (p less than 0.05), had a lower mean cardiac filling pressure (p less than 0.05), and had a higher hematocrit value (p less than 0.05) in the immediate postoperative period, all mean values for both groups were within the normal range. There were no differences between the two groups with regard to postoperative clinical parameters of cardiopulmonary and renal function, nor was outcome affected by the addition of albumin to the prime solution. We conclude that there is no clinically detectable advantage for the practice of adding 50 gm of albumin to the priming solution of bypass circuits in adults undergoing cardiac operations. Routinely supplementing the bypass prime solution with albumin adds significant cost, estimated to be approximately $10,000 per 100 cases, without demonstrable clinical benefits. Whether this practice can be of value in selected cases needs to be further studied.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
J. W. Hammon
Extracorporeal Circulation: Perfusion System
Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370.
[Full Text]


Home page
Card Surg AdultHome page
E. A. Hessel II and L. H. Edmunds Jr.
Extracorporeal Circulation: Perfusion Systems
Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338.
[Full Text]


Home page
ANN INTERN MEDHome page
M. M. Wilkes and R. J. Navickis
Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials
Ann Intern Med, August 7, 2001; 135(3): 149 - 164.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
V. W. Vanek
The Use of Serum Albumin as a Prognostic or Nutritional Marker and The Pros and Cons of IV Albumin Therapy
Nutr Clin Pract, June 1, 1998; 13(3): 110 - 122.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. M. Yim, L. C. Vermeulen, B. L. Erstad, K. A. Matuszewski, D. A. Burnett, and P. H. Vlasses
Albumin and Nonprotein Colloid Solution Use in US Academic Health Centers
Arch Intern Med, December 11, 1995; 155(22): 2450 - 2455.
[Abstract] [PDF]


Home page
PerfusionHome page
D. Scott, P.J. Hore, J. Cannata, K. Mason, B. Treagus, and J. Mullaly
A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery
Perfusion, November 1, 1995; 10(6): 415 - 424.
[Abstract] [PDF]


Home page
PerfusionHome page
I. R Jenkins and A. P Curtis
The combination of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass
Perfusion, September 1, 1995; 10(5): 301 - 305.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
R. L. Koretz
Intravenous Albumin and Nutrition Support: Going for the Quick Fix
JPEN J Parenter Enteral Nutr, March 1, 1995; 19(2): 166 - 171.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
G. E. Hastings and P. G. Wolf
The Therapeutic Use of Albumin
Arch Fam Med, November 1, 1992; 1(2): 281 - 287.
[Abstract] [PDF]


Home page
PerfusionHome page
L. Sandrelli, O. Alfieri II, and W. van Oeveren
The problem of priming solutions? The solution of priming problems
Perfusion, July 1, 1992; 7(3): 217 - 221.
[PDF]


Home page
Arch Intern MedHome page
B. L. Erstad, B. J. Gales, and W. D. Rappaport
The Use of Albumin in Clinical Practice
Arch Intern Med, May 1, 1991; 151(5): 901 - 911.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The American Association for Thoracic Surgery.